Tenon Medical Inc. (NASDAQ:TNON) shares jumped 23.77% to $3.02 in after-hours trading Wednesday after the California-based medical device company disclosed it repaid its outstanding convertible notes early.

Notes Retired Ahead of Maturity

According to its Wednesday Securities and Exchange Commission filing, Tenon repaid in full its original issue discount senior convertible promissory notes, carrying an aggregate principal balance of approximately $5.16 million.

The notes were issued Mar. 11 and were set to mature Sep. 11.

CEO Says Move Cuts Dilution Risk

President and CEO Steven M. Foster said, “We believe repaying the Notes ahead of maturity is an important step forward for Tenon as we continue to build momentum across our business.”

He added the repayment reduces dilution risk and preserves flexibility for continued commercialization.

Tenon Medical develops devices for treating disorders of the sacroiliac joint. Its products include the Catamaran SI Joint Fusion System, which uses a single titanium implant, and the SImmetry+ SI Joint Fusion System, a minimally invasive device that provides lateral access.

Trading Metrics, Technical Analysis

Tenon Medical has a market capitalization of $1.63 million, a 52-week high of $50.40 and a 52-week low of $2.40.

The Relative Strength Index (RSI) of TNON stands at 32.20.

The stock has dropped 93.99% over the past 12 months.

TNON is currently trading close to the lower end of its yearly range.

Price Action: The stock closed the regular session on Wednesday at $2.44, down 27.38%, according to Benzinga Pro data.

Benzinga’s Edge Stock Rankings indicate that Tenon Medical stock has a negative price trend across all time frames.

See More: Top Value Stocks

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Courtesy: vectorfusionart on Shutterstock.com